Professionals
-
AAOMS 2022 Position Paper update on Medication Related Osteonecrosis of the Jaw
Read the full update by clicking on the image below -
Risks of medication-related osteonecrosis of the jaw in cancer patients (RDH Magazine)
Click the image below to read, "Risks of medication-related osteonecrosis of the jaw in cancer patients" in the April 2021 edition of RDH Magazine ... -
Study Explores Jaw Problem Linked to Zoledronic Acid, Finds Risk Factors
Study Explores Jaw Problem Linked to Zoledronic Acid, Finds Risk Factors When cancer spreads to the bone, it can cause pain, fractures, and other p... -
Understanding Risks of MRONJ In Cancer Patients
photo credit: Update on Medicated-Related Osteonecrosis of the Jaw, Dental Academy of CE Published: January, 13 2019 Cancer survivors are at... -
Beyond Bisphosphonates – A Closer Look at MRONJ and Cancer Therapy
In 2014, the American Academy of Oral and Maxillofacial Surgeons released a position paper about medication–related osteonecrosis of the jaw (MRONJ... -
Bisphosphonates and Osteonecrosis of the Jaw
Bisphosphonates are incredible medications. By inhibiting the action of Osteoclasts, they can maintain bone integrity, prevent Skeletal Related Ev...
